PDS Biotechnology Corporation

PDSB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.91

+$0.07 (+8.09%)

At close: Sep 22, 2026, 4:00 PM ET

$0.90

-$0.01 (-0.85%)

After-hours: Sep 22, 2026, 7:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+8.09%

(1D)

Rating

Updated: Sep 18, 2026

31.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $50.89M

1D Range

0.81 0.99

52W Range

0.20 1.55

Valuation (TTM)

PE -1.25

PB 0.01

EV/EBITDA 2.50

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target $9

Cash Flow

FCF Yield -9325.2%

SBC Adj. FCF Yield -7972.5%

SBC Impact -14.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 34.7% | 8.1%

FCF 3Y | 5Y -146.8% | -97.2%

Returns

ROA -382.3%

ROE -708.2%

ROIC -3550.4%

Financial Health

Net Cash

$16.41B

Current Ratio 0.57

Interest Coverage -4.18

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV1...

Sector Healthcare

Industry Biotechnology

Employees 21

IPO Date Sep 29, 2015

Website www.pdsbiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+889.01%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞